Novo Nordisk shares fall
Novo Nordisk cut its full-year earnings outlook after reporting weaker-than-expected quarterly sales of its popular weight-loss drug Wegovy, raising concerns among investors about growing competition from Eli Lilly. The results end a prolonged run of positive earnings news from Europe’s most valuable listed company.
BELIEBTE BEITRÄGE
Bluetongue outbreak in a Portuguese sheep farm has broken out
September 19, 2024
Austria says disaster fund to rise to 1 billion euros
September 19, 2024
Portugal gets help from Spain and Morocco in response to fires
September 19, 2024
Drought reduces Amazon rivers to historic lows
September 19, 2024
LIVEÜBERTRAGUNG